MENU
PASG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Passage Bio (PASG) Ownership - Who owns Passage Bio?

Passage Bio Inc is a genetic medicines company... Show more

Profile

Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.56M
P/E Ratio
N/A
Total Cash
2.54M
Projected Growth
N/A
Total Debt
25.12M
Revenue
N/A
Risk (Beta)
2.58
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PASG
Capitalization
19.6M
P/E Ratio
N/A
Risk (Beta)
2.58
Dividend Yield
N/A
Total Cash
2.54M
Total Cash/Share
0.81
Total Debt
25.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
46.7M
P/B Ratio
0.42
Cash Flow
N/A
Earnings
-20.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
3.74
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-58.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-56.03
Shares Held By Institutions
11.4M
Shares Outstanding - Current
3.12M
Total Liabilities
39.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-44.719
View a ticker or compare two or three
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PASG showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com